HIGHLIGHTS
- who: . et al. from the Universitu00e9 libre Bruxelles, Belgium Clinical Pharmacology Department, La Paz University Hospital-IdiPAZ, Faculty of Medicine, Universidad Section), University of Alcalu00e1 (IRYCIS), Spain have published the research work: Editorial: Reducing the harm of medication - recent trends in pharmacovigilance (volume II), in the Journal: (JOURNAL)
- what: A FAERS-based study was conducted to compare adverse reaction reports and bleeding signals for ticagrelor and clopidogrel.
- how: The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.